发明名称 INHIBITION OF INFLAMMATION USING ANTAGONISTS OF MUC1
摘要 The invention provides for peptides from the MUC1 cytoplasmic domain and methods of use therefor. These peptides can inhibit MUC1 oligomerization, inhibit the interaction of MUC1 with NF-κB or a STAT, and block inflammatory response mediated by NF-κB or STAT signaling.
申请公布号 US2014187494(A1) 申请公布日期 2014.07.03
申请号 US201314138521 申请日期 2013.12.23
申请人 GENUS ONCOLOGY, LLC ;DANA-FARBER CANCER INSTITUTE, INC. 发明人 KUFE Donald W.;KHARBANDA Surender
分类号 C07K14/705;A61K45/06;A61K38/17 主分类号 C07K14/705
代理机构 代理人
主权项 1. A method of inhibiting inflammatory signaling in a subject suffering from acute pancreatitis comprising contacting said cell with a MUC1 peptide of at least 6 consecutive MUC1 residues and no more than 20 consecutive MUC1 residues and comprising the sequence CQCRRK.
地址 VERNON HILLS IL US